JAOA—The Journal of the American Osteopathic Association has joined the member journals of the International Committee of Medical Journal Editors (ICMJE)
1 in insisting that all phase 3 clinical trials be registered with at least one public registry. In addition, the
JAOA is requiring that all other trials involving human subjects, including pilot studies, be registered if they have one prospectively assigned concurrent control or comparison group.
To be considered for publication in the JAOA, all qualifying trials that begin on or after December 1, 2006, must be publicly registered before the trials begin. Researchers who submit manuscripts to the JAOA between September 1, 2006, and December 1, 2006, have until December 1, 2006, to register their trials. Manuscripts that were submitted to the JAOA before September 1, 2006, are exempt from this requirement.
The
JAOA agrees with the ICMJE's requirements for an acceptable public registry: “The registry must be electronically searchable and accessible to the public at no charge. It must be open to all registrants and be not for profit. It must have a mechanism to ensure the validity of the registration data.”
1 ClinicalTrials.gov, which is sponsored by the National Library of Medicine, is the most prominent registry in the United States that meets these requirements.
See the
JAOA's “Information for Contributors” on
pages 715-717 of this issue or
http://www.jaoa.org/misc/ifora.shtml for additional information concerning clinical trial registration and other aspects of manuscript submission. J
ournal contributors can also contact
JAOA Editorial Assistant Audrey K. Daniel by calling (800) 621-1773, extension 8166; by sending e-mail to
adaniel@osteopathic.org; by faxing messages to (312) 202-8466; or by writing to
JAOA—The Journal of the American Osteopathic Association, 142 E Ontario St, Chicago, IL 60611-2864.